FIRST PATIENT DOSED IN CITRYLL’S PHASE IIA TRIAL EVALUATING CIT-013 IN RHEUMATOID ARTHRITIS

Randomized multi-center study designed to assess the efficacy, safety, and tolerability of CIT-013 in patients with moderately active rheumatoid arthritis Oss, Netherlands – 2 September 2025 – Citryll, a biotech company pioneering a transformative approach to...

TargED Biopharmaceuticals Secures Prestigious EIC Grant to Accelerate Development of first-in-class Thrombolytic 

Utrecht, the Netherlands  TargED Biopharmaceuticals B.V., a pioneering Utrecht-based biotech company developing first-in-class biological drugs for thrombotic disorders, today announced that it has been awarded a prestigious blended finance grant from the...

Avidicure interviews with BioWorld News on how they are rethinking antibody engineering

Avidicure CEO Arthur Lahr spoke with Nuala Moran of BioWorld News about their $50M seed funding and how AVC-Boosters are designed to activate multiple immune pathways, unlocking powerful responses across both the innate and adaptive immune system. Read the full...

Avidicure Launches with $50 Million in Seed Financing to Develop New Multifunctional Antibody Modality to Treat Cancer

AVC-Boosters are designed as dual agonistic antibodies to safely deliver targeted and potentmonotherapy with broad application in oncology Lead product AVC-S-101 is a TROP2-targeting booster being developed for non-small cell lung cancer and multiple other cancer...

Sirius Medical and Mammotome Partner to Distribute Sirius Pintuition® Across the United States and Germany 

Cincinnati, Ohio, US and Eindhoven, Netherlands – February 27, 2025 – Sirius Medical, the innovator of Surgical Marker Navigation and Mammotome, a globally recognized leader in breast care, are proud to announce an exclusive distribution agreement for the United...

Sirius Medical Secures Scale-Up Funding to Further Advance its Surgical Marker Navigation portfolio and Expand its Global Presence 

 Eindhoven, the Netherlands – 4 February 2025 – As World Cancer Day is observed, Dutch medical device company Sirius Medical, the leader in surgical marker navigation, announced securing 10M€ in additional scale-up funding. This investment round was led by...